威廉体育

Research

  • Research platforms

    2024-04-11
  • Ningshao Xia:Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial.

    2024-04-10
  • Ningshao Xia:Safety and immunogenicity of a skin- and neuro-attenuated live vaccine for varicella: a randomized, double-blind, controlled, dose-escalation and age de-escalation phase 1 clinical trial

    2024-04-10
  • Ningshao Xia:Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection.

    2024-04-10
  • Zijian Zhou:Ferroptosis MRI for early detection of anticancer drug-induced acute cardiac/kidney injuries.

    2024-04-10
  • Ningshao Xia:Structure and proposed DNA delivery mechanism of a marine roseophage

    2024-04-10
  • Hwan-Ching Tai:Wood cellulose microfibrils have a 24-chain core-shell nanostructure in seed plants

    2024-04-10
  • Ningshao Xia:A SARS-CoV-2-specific CAR-T-cell model identifies felodipine, fasudil, imatinib, and caspofungin as potential treatments for lethal COVID-19

    2024-04-10
  • Quan Yuan:Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies

    2024-04-10
  • Zijian Zhou:Targeting the activity of T cells by membrane surface redox regulation for cancer theranostics

    2024-04-10
威廉体育 | 科技股份有限公司